| Product NDC: | 0409-1283 |
| Proprietary Name: | Hydromorphone Hydrochloride |
| Non Proprietary Name: | HYDROMORPHONE HYDROCHLORIDE |
| Active Ingredient(s): | 1 mg/mL & nbsp; HYDROMORPHONE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-1283 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200403 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111201 |
| Package NDC: | 0409-1283-31 |
| Package Description: | 10 SYRINGE in 1 BOX (0409-1283-31) > 1 mL in 1 SYRINGE |
| NDC Code | 0409-1283-31 |
| Proprietary Name | Hydromorphone Hydrochloride |
| Package Description | 10 SYRINGE in 1 BOX (0409-1283-31) > 1 mL in 1 SYRINGE |
| Product NDC | 0409-1283 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HYDROMORPHONE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20111201 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |